Enanta Pharmaceuticals Stock Price Prediction
| ENTA Stock | USD 13.23 0.77 5.50% |
Oversold Vs Overbought
57
Oversold | Overbought |
Enanta Pharmaceuticals stock price prediction is an act of determining the future value of Enanta Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Enanta Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Enanta Pharmaceuticals and does not consider all of the tangible or intangible factors available from Enanta Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Enanta Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Enanta Pharmaceuticals' stock price prediction:Quarterly Earnings Growth (0.66) | EPS Estimate Next Quarter (1.25) | EPS Estimate Current Year (5.09) | EPS Estimate Next Year (4.67) | Wall Street Target Price 22.29 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Enanta Pharmaceuticals based on different types of headlines from major news networks to social media. The Enanta stock price prediction module provides an analysis of price elasticity to changes in media outlook on Enanta Pharmaceuticals over a specific investment horizon. Using Enanta Pharmaceuticals hype-based prediction, you can estimate the value of Enanta Pharmaceuticals from the perspective of Enanta Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Enanta Pharmaceuticals using Enanta Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Enanta using crowd psychology based on the activity and movement of Enanta Pharmaceuticals' stock price.
Enanta Pharmaceuticals Implied Volatility | 671.99 |
Enanta Pharmaceuticals' implied volatility exposes the market's sentiment of Enanta Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Enanta Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Enanta Pharmaceuticals stock will not fluctuate a lot when Enanta Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Enanta Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Enanta Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Enanta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Enanta Pharmaceuticals after-hype prediction price | USD 13.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Enanta |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Enanta Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Enanta Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Enanta Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enanta Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Enanta Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Enanta Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Enanta Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enanta Pharmaceuticals' historical news coverage. Enanta Pharmaceuticals' after-hype downside and upside margins for the prediction period are 9.30 and 16.86, respectively. We have considered Enanta Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Enanta Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Enanta Pharmaceuticals is based on 3 months time horizon.
Enanta Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Enanta Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enanta Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enanta Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.25 | 3.78 | 0.15 | 0.00 | 10 Events / Month | 12 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
13.23 | 13.08 | 1.13 |
|
Enanta Pharmaceuticals Hype Timeline
Enanta Pharmaceuticals is currently traded for 13.23. The entity has historical hype elasticity of -0.15, and average elasticity to hype of competition of 0.0. Enanta is anticipated to decline in value after the next headline, with the price expected to drop to 13.08. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.13%, whereas the daily expected return is currently at 0.25%. The volatility of related hype on Enanta Pharmaceuticals is about 107100.0%, with the expected price after the next announcement by competition of 13.23. About 94.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.81. Some equities with similar Price to Book (P/B) outperform the market in the long run. Enanta Pharmaceuticals has Price/Earnings (P/E) ratio of 366.13. The entity recorded a loss per share of 6.57. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Enanta Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Enanta Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Enanta Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Enanta Pharmaceuticals' future price movements. Getting to know how Enanta Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enanta Pharmaceuticals may potentially react to the hype associated with one of its peers.
Enanta Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Enanta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enanta using various technical indicators. When you analyze Enanta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Enanta Pharmaceuticals Predictive Indicators
The successful prediction of Enanta Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Enanta Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Enanta Pharmaceuticals based on analysis of Enanta Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Enanta Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Enanta Pharmaceuticals's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.002035 | 0.001809 | Price To Sales Ratio | 2.66 | 2.53 |
Story Coverage note for Enanta Pharmaceuticals
The number of cover stories for Enanta Pharmaceuticals depends on current market conditions and Enanta Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enanta Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enanta Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Enanta Pharmaceuticals Short Properties
Enanta Pharmaceuticals' future price predictability will typically decrease when Enanta Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enanta Pharmaceuticals often depends not only on the future outlook of the potential Enanta Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enanta Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21 M | |
| Cash And Short Term Investments | 369.9 M |
Check out Enanta Pharmaceuticals Basic Forecasting Models to cross-verify your projections. For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Enanta Stock analysis
When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Enanta Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. If investors know Enanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enanta Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (6.57) | Revenue Per Share 3.5 | Quarterly Revenue Growth (0.24) | Return On Assets (0.23) |
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enanta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enanta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enanta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.